Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Retatrutide is still an experimental drug in clinical trials
A recent study conducted in an academic medical center determined the pattern of GLP-1 agonist use and showed that primary care physicians accounted for 45.1%, endocrinologists 45.0%, and cardiologists 1.4% of all prescriptions
These medications work by binding to receptors in the brain, pancreas, and gastrointestinal tract, creating multiple physiological effects that support weight reduction
They may cause some individuals to discontinue the drug or reduce the dose, so adhering to the regimen might require modifications in administration and timing
Frequently Asked Questions Do I pay more for higher dosages
US$ 21.99
US$ 29.86
US$ 27.23
US$ 23.66
